7-Epi Clindamycin

CAS: 16684-06-3

Ref. TR-E582485

Produktinformation

• Name: 7-Epi Clindamycin
• Synonyme: D-erythro-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, D-erythro-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans- α- (8CI), D-erythro-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, (2S-trans)-, 7-Epiclindamycin, Antibiotic U 21251F, Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-α-D-galacto-octopyranoside
• Marke: TRC
• Beschreibung: Impurity Clindamycin EP Impurity CApplications 7-Epiclindamycin (Clindamycin EP Impurity C) is an epimer of Clindamycin (C580000), which is a semi-synthetic antibiotic prepared from Lincomycin, an antibacterial. In addition, 7-Epiclindamycin is an intermediate in synthesizing 7-Epiclindamycin 2-Phosphate (>90%) (E582505), which is an another impurity of Clindamycin.References Birkenmeyer, R., et al.: J. Med. Chem., 13, 616 (1970), Platzer, D., et al.: J. Pharm. Biomed. Anal., 41, 84 (2006), Platzer, D., et al.: J. Pharm. Biomed. Anal., 41, 84 (2006); Oesterling, et al.: J. Pharm. Sci., 59, 63 (1970); Gray, J.E., et al.: Toxicol. Appl. Pharmacol., 21, 516 (1972); Brown, L.W., et al.: Anal. Profiles Drug Subs., 10, 75 (1981)

Chemische Eigenschaften

• Molekulargewicht: 424.98
• Formel: C₁₈H₃₃ClN₂O₅S
• Farbe/Form: Neat
• InChl: InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10-,11+,12-,13+,14-,15-,16-,18-/m1/s1
• InChI Key: InChIKey=KDLRVYVGXIQJDK-KIDUDLJLSA-N
• SMILES: CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1